Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 16/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 16/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14106339 | 0.76 | KMT2A (0.50) | ALDH1A1 | |
| SCHEMBL27911199 | 0.74 | ACACB (0.56) | GRM2ALDH1A1TSHRHCRTR1HCRTR2 | |
| SCHEMBL11100815 | 0.73 | CHRM5 (0.56) | GRM2ALDH1A1TSHRCHRM5HCRTR1 | |
| SCHEMBL4537702 | 0.71 | HCRTR1 (0.54) | ALDH1A1TSHRCHRM5HCRTR1HCRTR2 | |
| SCHEMBL14047401 | 0.70 | ALDH1A1 (0.57) | GRM2ALDH1A1TSHRCHRM5HCRTR1 | |
| SCHEMBL6158458 | 0.69 | GRM2 (0.50) | GRM2ALDH1A1TSHRHCRTR1HCRTR2 | |
| SCHEMBL12625981 | 0.68 | ALDH1A1 (0.66) | GRM2ALDH1A1TSHRCHRM5 | |
| SCHEMBL2024493 | 0.68 | MEN1 (0.58) | GRM2ALDH1A1TSHRCHRM5HCRTR1 | |
| SCHEMBL27630234 | 0.67 | ALDH1A1 (0.69) | ALDH1A1TSHR | |
| SCHEMBL2896653 | 0.67 | GRM2 (0.67) | GRM2ALDH1A1TSHRHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2429523-A1 | THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2012-03-21 | — | — | EP | claimed |
| WO-2010131191-A1 | THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2010-11-18 | — | — | WO | claimed |
| EP-2429523-A1 | THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2012-03-21 | — | — | EP | disclosed |
| WO-2010131191-A1 | THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2010-11-18 | — | — | WO | disclosed |